Israel-based Check-Cap, a clinical stage medical diagnostics company that is working on an ingestible sensor capsule to screen for colorectal cancer, has entered into an agreement with a single healthcare company for $5.9 million in financing. Check-Cap, which does not have a commercial product as of yet, will use the net proceeds from the offering to advance the ongoing clinical development of...
